Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 2
2012 5
2013 5
2014 7
2015 10
2016 7
2017 8
2018 8
2019 11
2020 12
2021 21
2022 25
2023 33
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Devinsky O, et al. Among authors: jutras aswad d. Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Epilepsia. 2014. PMID: 24854329 Free PMC article. Review.
Letter in Reply.
Hassan AN, Wild C, Jutras-Aswad D. Hassan AN, et al. Among authors: jutras aswad d. J Addict Med. 2023 Nov-Dec 01;17(6):746. doi: 10.1097/ADM.0000000000001203. Epub 2023 Jul 27. J Addict Med. 2023. PMID: 37934553 No abstract available.
Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
Tourjman SV, Buck G, Jutras-Aswad D, Khullar A, McInerney S, Saraf G, Pinto JV, Potvin S, Poulin MJ, Frey BN, Kennedy SH, Lam RW, MacQueen G, Milev R, Parikh SV, Ravindran A, McIntyre RS, Schaffer A, Taylor VH, van Ameringen M, Yatham LN, Beaulieu S. Tourjman SV, et al. Among authors: jutras aswad d. Can J Psychiatry. 2023 May;68(5):299-311. doi: 10.1177/07067437221099769. Epub 2022 Jun 16. Can J Psychiatry. 2023. PMID: 35711159 Free PMC article. Review.
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trials.
Bakouni H, Sharafi H, Bahremand A, Drouin S, Ziegler D, Bach P, Le Foll B, Schütz CG, Tardelli V, Ezard N, Siefried K, Jutras-Aswad D. Bakouni H, et al. Among authors: jutras aswad d. Drug Alcohol Depend. 2023 Dec 1;253:111018. doi: 10.1016/j.drugalcdep.2023.111018. Epub 2023 Nov 4. Drug Alcohol Depend. 2023. PMID: 37979478 Review.
Use of non-medical cannabis in epilepsy: A scoping review.
Li J, Areal CC, Toffa DH, Citherlet D, Deacon C, Jutras-Aswad D, Keezer MR, Nguyen DK. Li J, et al. Among authors: jutras aswad d. Front Neurol. 2023 Mar 6;14:1132106. doi: 10.3389/fneur.2023.1132106. eCollection 2023. Front Neurol. 2023. PMID: 36949852 Free PMC article.
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report.
Garel N, Greenway KT, Dinh-Williams LL, Thibault-Levesque J, Jutras-Aswad D, Turecki G, Rej S, Richard-Devantoy S. Garel N, et al. Among authors: jutras aswad d. Neuropsychopharmacology. 2023 Nov;48(12):1769-1777. doi: 10.1038/s41386-023-01689-y. Epub 2023 Aug 2. Neuropsychopharmacology. 2023. PMID: 37532888 Free PMC article.
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sharafi H, Bakouni H, McAnulty C, Drouin S, Coronado-Montoya S, Bahremand A, Bach P, Ezard N, Le Foll B, Schütz CG, Siefried KJ, Tardelli VS, Ziegler D, Jutras-Aswad D. Sharafi H, et al. Among authors: jutras aswad d. Addiction. 2024 Feb;119(2):211-224. doi: 10.1111/add.16347. Epub 2023 Oct 25. Addiction. 2024. PMID: 37880829 Review.
Die 'Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)': EMPFEHLUNGEN[The 'Lower-Risk Cannabis Use Guidelines (LRCUG)': RECOMMENDATIONS (GERMAN)].
Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, Pacula R, Rehm J, Room R, van den Brink W, Hall W. Fischer B, et al. Among authors: jutras aswad d. Int J Drug Policy. 2023 Mar 24:103995. doi: 10.1016/j.drugpo.2023.103995. Online ahead of print. Int J Drug Policy. 2023. PMID: 36967339 No abstract available.
Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder.
Enns B, Krebs E, Whitehurst DGT, Jutras-Aswad D, Le Foll B, Socias ME, Nosyk B; OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Enns B, et al. Among authors: jutras aswad d. Drug Alcohol Depend. 2023 Jun 1;247:109893. doi: 10.1016/j.drugalcdep.2023.109893. Epub 2023 Apr 23. Drug Alcohol Depend. 2023. PMID: 37120920 Clinical Trial.
145 results